Encysive Drug Study Comes to an End

Encysive Pharmaceuticals today announced topline results from the Company's multi- center, pivotal Phase III STRIDE-2 (Sitaxsentan To Relieve ImpaireD Exercise) trial.

Verizon Wins MCI

In another big merger for the telecommunications industry, Verizon will acquire MCI for $5.3 billion.